AR and chronic obstructive pulmonary disease: Sex hormones also modulate systemic inflammation; for example, androgens have been shown to suppress the immune system.34 Therefore, the sex differences we report could reflect differences in sex hormone levels between female and male COPD patients, which would support the use of androgenic agents, such as selective androgen receptor modulators, in the treatment of COPD-related muscle wasting, particularly in females.